Companies have stepped forward with innovative products in the areas of personal protective equipment, testing and diagnostics, safety and automation, and others in the fight against the COVID-19 pandemic.
The Virus Surface to a Novel COVID-19 Vaccine Candidate: The Journey of the SARS-CoV-2 Spike Protein
Intensive analysis of the spike protein led to the development of the first vaccine candidate approved for clinical trials. Perhaps overshadowed, is the unprecedented collaboration between academic scientists, government institutions, and private industry central to this remarkable work.
High-resolution cryo-electron microscopy imaging of the CoV spike protein complex has revealed both expected and novel structural elements – signifying capabilities previously not observed in this family of coronaviruses..
Challenges with the approval of COVID-19 test diagnostics uncovered serious process issues that are now being resolved in order to contain the current outbreak and to fight future pathogens.
The LUMOS II is as an easy-to-use, stand-alone FT-IR microscope with peak performance across transmission, reflection, or attenuated total reflectance (ATR) modes.
With more than 4100 published studies (as of Oct 2019) and growing, nowhere is the power of Droplet Digital PCR technology further apparent than Bio-Rad’s expansive ddPCR Publications Database.
Cannabis research is approaching a differentiation and maturation phase – where public and private efforts are yielding substantial growth for the medicinal cannabis field.